Colgate-Palmolive (CL) Projected to Post Earnings on Friday

Colgate-Palmolive (NYSE:CLGet Free Report) is expected to issue its Q4 2025 results before the market opens on Friday, January 30th. Analysts expect Colgate-Palmolive to post earnings of $0.92 per share and revenue of $5.1288 billion for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, January 30, 2026 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.Colgate-Palmolive’s revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.91 earnings per share. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Stock Up 1.2%

CL stock opened at $85.78 on Friday. The company has a market cap of $69.14 billion, a price-to-earnings ratio of 24.03, a P/E/G ratio of 5.74 and a beta of 0.30. Colgate-Palmolive has a twelve month low of $74.54 and a twelve month high of $100.18. The business has a 50 day moving average price of $79.89 and a two-hundred day moving average price of $81.62. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CL. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a report on Tuesday, December 9th. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a report on Friday, October 10th. Barclays set a $83.00 price target on Colgate-Palmolive in a report on Friday, January 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Eleven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

Get Our Latest Report on Colgate-Palmolive

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently made changes to their positions in CL. Amundi grew its position in shares of Colgate-Palmolive by 41.6% in the third quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after purchasing an additional 1,850,412 shares during the last quarter. Two Sigma Investments LP boosted its stake in Colgate-Palmolive by 360.9% in the 3rd quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock valued at $169,972,000 after purchasing an additional 1,664,949 shares during the period. Canada Pension Plan Investment Board boosted its stake in Colgate-Palmolive by 392.8% in the 2nd quarter. Canada Pension Plan Investment Board now owns 1,278,987 shares of the company’s stock valued at $116,260,000 after purchasing an additional 1,019,471 shares during the period. Invesco Ltd. grew its holdings in Colgate-Palmolive by 13.1% in the 3rd quarter. Invesco Ltd. now owns 8,467,993 shares of the company’s stock valued at $676,931,000 after buying an additional 978,943 shares in the last quarter. Finally, Voloridge Investment Management LLC bought a new position in Colgate-Palmolive during the 3rd quarter worth $49,925,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Read More

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.